128 related articles for article (PubMed ID: 11942328)
1. Histogenesis of nonurothelial carcinomas of the urinary bladder from pre-existent transitional cell carcinomas. A histopathological and immunohistochemical study.
Kunze E; Francksen B
Urol Res; 2002 Mar; 30(1):66-78. PubMed ID: 11942328
[TBL] [Abstract][Full Text] [Related]
2. Expression of MUC5AC apomucin in transitional cell carcinomas of the urinary bladder and its possible role in the development of mucus-secreting adenocarcinomas.
Kunze E; Francksen B; Schulz H
Virchows Arch; 2001 Nov; 439(5):609-15. PubMed ID: 11764379
[TBL] [Abstract][Full Text] [Related]
3. Histogenesis of nonurothelial carcinomas in the human and rat urinary bladder.
Kunze E
Exp Toxicol Pathol; 1998 Sep; 50(4-6):341-55. PubMed ID: 9784006
[TBL] [Abstract][Full Text] [Related]
4. Tumor-associated neoexpression of the pS2 peptide and MUC5AC mucin in primary adenocarcinomas and signet ring cell carcinomas of the urinary bladder.
Kunze E; Krassenkova I; Fayyazi A
Histol Histopathol; 2008 May; 23(5):539-48. PubMed ID: 18283638
[TBL] [Abstract][Full Text] [Related]
5. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.
Kunze E; Wendt M; Schlott T
Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403
[TBL] [Abstract][Full Text] [Related]
6. Transitional cell carcinomas and nonurothelial carcinomas of the urinary bladder differ in the promoter methylation status of the caveolin-1, hDAB2IP and p53 genes, but not in the global methylation of Alu elements.
Kunze E; Von Bonin F; Werner C; Wendt M; Schlott T
Int J Mol Med; 2006 Jan; 17(1):3-13. PubMed ID: 16328005
[TBL] [Abstract][Full Text] [Related]
7. Clear cell carcinoma of the urinary bladder: a report and comparison of four tumors of mullerian origin and nine of probable urothelial origin with discussion of histogenesis and diagnostic problems.
Oliva E; Amin MB; Jimenez R; Young RH
Am J Surg Pathol; 2002 Feb; 26(2):190-7. PubMed ID: 11812940
[TBL] [Abstract][Full Text] [Related]
8. Urinary bladder carcinoma with a neoplastic squamous component: a mapping study of 31 cases.
Sakamoto N; Tsuneyoshi M; Enjoji M
Histopathology; 1992 Aug; 21(2):135-41. PubMed ID: 1505930
[TBL] [Abstract][Full Text] [Related]
9. Expression of bcl-2 and p53 oncoproteins in schistosomiasis-associated transitional and squamous cell carcinoma of urinary bladder.
Chaudhary KS; Lu QL; Abel PD; Khandan-Nia N; Shoma AM; el Baz M; Stamp GW; Lalani EN
Br J Urol; 1997 Jan; 79(1):78-84. PubMed ID: 9043502
[TBL] [Abstract][Full Text] [Related]
10. Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin, and cytokeratin 20 in noninvasive, invasive, and metastatic urothelial (transitional cell) carcinomas.
Parker DC; Folpe AL; Bell J; Oliva E; Young RH; Cohen C; Amin MB
Am J Surg Pathol; 2003 Jan; 27(1):1-10. PubMed ID: 12502922
[TBL] [Abstract][Full Text] [Related]
11. Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression.
Quentin T; Schlott T; Korabiowska M; Käthei N; Zöller G; Glaser F; Kunze E
Anticancer Res; 2004; 24(5A):2745-56. PubMed ID: 15517881
[TBL] [Abstract][Full Text] [Related]
12. Altered mRNA expression of the Rb and p16 tumor suppressor genes and of CDK4 in transitional cell carcinomas of the urinary bladder associated with tumor progression.
Quentin T; Henke C; Korabiowska M; Schlott T; Zimmerman B; Kunze E
Anticancer Res; 2004; 24(2B):1011-23. PubMed ID: 15161057
[TBL] [Abstract][Full Text] [Related]
13. Epithelial differentiation antigens and epidermal growth factor receptors in transitional cell bladder carcinoma: correlation with prognosis.
Nakopoulou L; Zervas A; Constantinides C; Deliveliotis C; Stefanaki K; Dimopoulos C
Urol Int; 1995; 54(4):191-7. PubMed ID: 7541921
[TBL] [Abstract][Full Text] [Related]
14. Sarcomatoid carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical analysis of 14 patients.
Ikegami H; Iwasaki H; Ohjimi Y; Takeuchi T; Ariyoshi A; Kikuchi M
Hum Pathol; 2000 Mar; 31(3):332-40. PubMed ID: 10746676
[TBL] [Abstract][Full Text] [Related]
15. Clinical implications of the expression of epidermal growth factor receptors in human transitional cell carcinoma.
Messing EM
Cancer Res; 1990 Apr; 50(8):2530-7. PubMed ID: 1690599
[TBL] [Abstract][Full Text] [Related]
16. Squamous and glandular differentiation in urothelial bladder carcinomas. Histopathology, histochemistry and immunohistochemical expression of carcinoembryonic antigen.
López-Beltrán A; Martín J; García J; Toro M
Histol Histopathol; 1988 Jan; 3(1):63-8. PubMed ID: 2980209
[TBL] [Abstract][Full Text] [Related]
17. Histogenesis of nonurothelial carcinomas of the urinary bladder from pre-existent transitional cell carcinomas. A histopathological and immunohistochemical study.
Montie JE
J Urol; 2005 Apr; 173(4):1173-4. PubMed ID: 15758735
[No Abstract] [Full Text] [Related]
18. Cytokeratin 14 as a marker of squamous differentiation in transitional cell carcinomas.
Harnden P; Southgate J
J Clin Pathol; 1997 Dec; 50(12):1032-3. PubMed ID: 9516889
[TBL] [Abstract][Full Text] [Related]
19. Malignant glandular lesions and glandular differentiation in invasive/noninvasive urothelial carcinoma of the urinary bladder.
Behzatoğlu K
Ann Diagn Pathol; 2011 Dec; 15(6):422-6. PubMed ID: 21855380
[TBL] [Abstract][Full Text] [Related]
20. Correlation between numbers of desmosomes and the aggressiveness of transitional cell carcinoma in human urinary bladder.
Alroy J; Pauli BU; Weinstein RS
Cancer; 1981 Jan; 47(1):104-12. PubMed ID: 7459799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]